Case-control study for the identification of virological factors associated with fulminant hepatitis B

Hepatology Research

Volumn 39, Issue 7, 2009, Pages 648-656

  Kusakabe, Atsunori ^a   Tanaka, Yasuhito ^a   Mochida, Satoshi ^b   Nakayama, Nobuaki ^b   Inoue, Kazuaki ^c   Sata, Michio ^d   Isoda, Norio ^e   Kang, Jong Hon ^f   Sumino, Yasukiyo ^g   Yatsuhashi, Hiroshi ^h   Takikawa, Yasuhiro ⁱ   Kaneko, Shuichi ^j   Yamada, Gotaro ^k   Karino, Yoshiyasu ^l   Tanaka, Eiji ^m   Kato, Junji ⁿ   Sakaida, Isao ^o   Izumi, Namiki ^p   Sugauchi, Fuminaka ^a   Nojiri, Shunsuke ^a   Joh, Takashi ^a   Miyakawa, Yuzo ^q   Mizokami, Masashi ^a,r   more..

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f TEINE KEIJINKAI HOSPITAL   (Japan)

^g TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^h NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

ⁱ IWATE MEDICAL UNIVERSITY   (Japan)

^j KANAZAWA UNIVERSITY   (Japan)

^k Kawasaki Hospital   (Japan)

^l Sapporo Kosei General Hospital   (Japan)

^m SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁿ SAPPORO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^o YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

^p MUSASHINO RED CROSS HOSPITAL   (Japan)

^q Miyakawa Memorial Research Foundation   (Japan)

^r 1 7 1 Kohnodai   (Japan)

more..

Author keywords

Acute exacerbation of asymptomatic hepatitis B virus carrier; Fulminant hepatitis; Genotypes; Transient hepatitis B virus infection

Indexed keywords

BILIRUBIN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; VIRUS CARRIER; VIRUS IDENTIFICATION;

EID: 67649625538     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00519.x     Document Type: Article

References (40)

1. Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G. Fulminant hepatitis and late onset hepatic failure in Japan. Hepatol Res 2008; 38: 646-57.
2. Norder H, Hammas B, Lofdahl S, Courouce AM, Magnius LO. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 1992; 73 (Pt 5): 1201-8.
3. Okamoto H, Tsuda F, Sakugawa H et al. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes. J Gen Virol 1988; 69: 2575-83.
4. Stuyver L, De Gendt S, Van Geyt C et al. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness. J Gen Virol 2000; 81 (Pt 1): 67-74.
5. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: A new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002; 83 (Pt 8): 2059-73.
6. Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology 2003; 46: 329-38.
7. Chu CJ, Lok AS. Clinical significance of hepatitis B virus genotypes. Hepatology 2002; 35: 1274-6.
8. Tanaka Y, Hasegawa I, Kato T et al. A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology 2004; 40: 747-55.
9. Sugauchi F, Orito E, Ichida T et al. Hepatitis B virus of genotype B with or without recombination with genotype C over the pre-core region plus the core gene. J Virol 2002; 76: 5985-92.
10. Huy TT, Ushijima H, Quang VX et al. Genotype C of hepatitis B virus can be classified into at least two subgroups. J Gen Virol 2004; 85 (Pt 2): 283-92.
11. Tanaka Y, Orito E, Yuen MF et al. Two subtypes (subgenotypes) of hepatitis B virus genotype C: A novel subtyping assay based on restriction fragment length polymorphism. Hepatol Res 2005; 33: 216-24.
12. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 1997; 175: 1285-93.
13. Sato S, Suzuki K, Akahane Y et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995; 122: 241-8.
14. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the pre-core region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324: 1699-704.
15. Ozasa A, Tanaka Y, Orito E et al. Influence of genotypes and pre-core mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 2006; 44: 326-34.
16. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991; 324: 1705-9.
17. Imamura T, Yokosuka O, Kurihara T et al. Distribution of hepatitis B viral genotypes and mutations in the core promoter and pre-core regions in acute forms of liver disease in patients from Chiba, Japan. Gut 2003; 52: 1630-7.
18. Sugiyama M, Tanaka Y, Kurbanov F, Nakayama N, Mochida S, Mizokami M. Influences on hepatitis B virus replication by a naturally occurring mutation in the core gene. Virology 2007; 365: 285-91.
19. Laskus T, Persing DH, Nowicki MJ, Mosley JW, Rakela J. Nucleotide sequence analysis of the pre-core region in patients with fulminant hepatitis B in the United States. Gastroenterology 1993; 105: 1173-8.
20. Liang TJ, Hasegawa K, Munoz SJ et al. Hepatitis B virus pre-core mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. J Clin Invest 1994; 93: 550-5.
21. Feray C, Gigou M, Samuel D, Bernuau J, Bismuth H, Brechot C. Low prevalence of pre-core mutations in hepatitis B virus DNA in fulminant hepatitis type B in France. J Hepatol 1993; 18: 119-22.
22. Karayiannis P, Alexopoulou A, Hadziyannis S et al. Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors. Hepatology 1995; 22: 1628-34.
23. Trey C, Lipworth L, Chalmers TC et al. Fulminant hepatic failure. Presumable contribution to halothane. N Engl J Med 1968; 279: 798-801.
24. Ng HJ, Lim LC. Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: Case report. Ann Hematol 2001; 80: 549-52.
25. Fujiwara K, Mochida S, Matsui A. [Prospective study for the efficiency of lamivudine for the patients with acute exacerbation of HBV carrier.] Annual Report of Intractable Liver Disease Study Group of Japan, the Ministry of Health, Welfare and Labor 2004. (In Japanese.)
26. Kimura T, Rokuhara A, Sakamoto Y et al. Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol 2002; 40: 439-45.
27. Kimura T, Rokuhara A, Matsumoto A et al. New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA. J Clin Microbiol 2003; 41: 1901-6.
28. Abe A, Inoue K, Tanaka T et al. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 1999; 37: 2899-903.
29. Sugauchi F, Mizokami M, Orito E et al. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol 2001; 82 (Pt 4): 883-92.
30. Shin IT, Tanaka Y, Tateno Y, Mizokami M. Development and public release of a comprehensive hepatitis virus database. Hepatol Res 2008; 38: 234-43.
31. Chisari FV, Ferrari C Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29-60.
32. Carman WF, Jacyna MR, Hadziyannis S et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 2 (8663): 588-91.
33. Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on pre-core gene expression and viral replication. J Virol 1996; 70: 5845-51.
34. Okamoto H, Tsuda F, Akahane Y et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994; 68: 8102-10.
35. Lamberts C, Nassal M, Velhagen I, Zentgraf H, Schroder CH. Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis. J Virol 1993; 67: 3756-62.
36. Chen MT, Billaud JN, Sallberg M et al. A function of the hepatitis B virus pre-core protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci USA 2004; 101: 14913-8.
37. Chen M, Sallberg M, Hughes J et al. Immune tolerance split between hepatitis B virus pre-core and core proteins. J Virol 2005; 79: 3016-27.
38. Bocharov G, Ludewig B, Bertoletti A et al. Underwhelming the immune response: Effect of slow virus growth on CD8+-T-lymphocyte responses. J Virol 2004; 78: 2247-54.
39. Sainokami S, Abe K, Sato A et al. Initial load of hepatitis B virus (HBV), its changing profile, and pre-core/core promoter mutations correlate with the severity and outcome of acute HBV infection. J Gastroenterol 2007; 42: 241-9.
40. Tassopoulos NC, Papaevangelou GJ, Roumeliotou-Karayannis A, Ticehurst JR, Feinstone SM, Purcell RH. Search for hepatitis B virus DNA in sera from patients with acute type B or non-A, non-B hepatitis. J Hepatol 1986; 2: 410-8.